MedTrace Logo

Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

NCT06435884 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2026-03-05

No results posted yet for this study

Summary

CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Conditions

  • Atrophic Scar

Sponsors & Collaborators

  • CellinCells

    lead INDUSTRY

Principal Investigators

  • JongHee Lee, MD · Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-06
Primary Completion
2029-09-30
Completion
2029-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06435884 on ClinicalTrials.gov